Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Net Income: 2024-2025

Historic Net Income for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -$74.1 million.

  • Kura Oncology's Net Income fell 36.23% to -$74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$214.9 million, marking a year-over-year change of. This contributed to the annual value of -$174.0 million for FY2024, which is 13.99% down from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Net Income is -$74.1 million, which was down 12.09% from -$66.1 million recorded in Q2 2025.
  • Kura Oncology's 5-year Net Income high stood at -$17.2 million for Q4 2024, and its period low was -$74.1 million during Q3 2025.
  • Over the past 2 years, Kura Oncology's median Net Income value was -$54.4 million (recorded in 2024), while the average stood at -$52.8 million.
  • Data for Kura Oncology's Net Income shows a maximum YoY crashed of 36.23% (in 2025) over the last 5 years.
  • Kura Oncology's Net Income (Quarterly) stood at -$17.2 million in 2024, then slumped by 36.23% to -$74.1 million in 2025.
  • Its last three reported values are -$74.1 million in Q3 2025, -$66.1 million for Q2 2025, and -$57.4 million during Q1 2025.